Horm Metab Res 2002; 34(11/12): 737-745
DOI: 10.1055/s-2002-38265
Review
© Georg Thieme Verlag Stuttgart · New York

Adipose Tissue Intracrinology: Potential Importance of Local Androgen/Estrogen Metabolism in the Regulation of Adiposity

C.  Bélanger 1 , V.  Luu-The 1 , P.  Dupont 2 , A.  Tchernof 1, 3
  • 1 Molecular Endocrinology and Oncology Research Center
  • 2 Gynecology Unit
  • 3 Department of Food Sciences and Nutrition, Laval University Hospital Research Center (CHUL Research Center) and Laval University, Quebec, Canada
Further Information

Publication History

Received 7 October 2002

Accepted after revision 15 November 2002

Publication Date:
27 March 2003 (online)

Abstract

The present article summarizes some of the studies available on steroid hormone conversion through the specific expression of steroidogenic enzymes in adipose tissue (adipose tissue intracrinology) and discusses the potential impact of local adipose tissue steroid metabolism on the regulation of adipocyte function and other metabolic parameters. Several studies have demonstrated significant steroid hormone uptake and conversion by adipose tissues from various body sites and in various cell fractions. Activities and/or mRNAs of aromatase, 3β-hydroxysteroid dehydrogenase (HSD), 3α-HSD, 11β-HSD, 17β-HSD, 7α-hydroxylase, 17α-hydroxylase, 5α-reductase and UDP-glucuronosyltransferase 2B15 have been detected in adipose tissue or adipose cells. These studies have demonstrated potentially important roles for these enzymes in obesity, central fat accumulation, and the metabolic syndrome. Future studies on adipose tissue intracrinology will contribute further to our understanding of steroid action in adipocytes.

References

  • 1 Kissebah A H, Krakower G R. Regional adiposity and morbidity.  Physiol Rev. 1994;  74 761-811
  • 2 Després J P, Moorjani S, Ferland M, Tremblay Y, Lupien P J, Nadeau A, Pinault S, Thériault G, Bouchard C. Adipose tissue distribution and plasma lipoprotein levels in obese women: importance of intra-abdominal fat.  Arteriosclerosis. 1989;  9 203-210
  • 3 Kalin M F, Zumoff B. Sex hormones and coronary disease: a review of the clinical studies.  Steroids. 1990;  55 330-352
  • 4 Barrett-Connor E. Heart disease in women.  Fertil Steril. 1994;  62 (Suppl. 2) 127S-132S
  • 5 Tchernof A, Després J P. Sex steroid hormones, sex hormone-binding globulin, and adiposity in men and women.  Horm Metab Res. 2000;  32 526-536
  • 6 Labrie F. Intracrinology.  Mol Cell Endocrinol. 1991;  78 C113-C118
  • 7 Simpson E R. Role of aromatase in sex steroid action.  J Mol Endocrinol. 2000;  25 149-156
  • 8 Corbould A M, Judd S J, Rodgers R J. Expression of types 1, 2, and 3 17β-hydroxysteroid dehydrogenase in subcutaneous abdominal and intra-abdominal adipose tissue of women.  J Clin Endocrinol Metab. 1998;  83 187-194
  • 9 Twombly G H, Basset M, Meisel D, Levitz M. Estrogen storage in fat.  Am J Obstet Gynecol. 1967;  99 785-795
  • 10 Bolt H M, Gobel P. Formation of estrogens from androgens by human subcutaneous adipose tissue in vitro.  Horm Metab Res. 1972;  4 312-313
  • 11 Schindler A E, Ebert A, Friedrich E. Conversion of androstenedione to estrone by human tissue.  J Clin Endocrinol Metab. 1972;  35 627-630
  • 12 Nimrod A, Ryan K. Aromatization of androgens by human abdominal and breast fat tissue.  J Clin Endocrinol Metab. 1975;  40 367-372
  • 13 Fehér T, Halmy L. Dehydroepiandrosterone and dehydroepiandrosterone sulfate dynamics in obesity.  Can J Biochem. 1975;  53 215-222
  • 14 Fehér T, Halmy L, Bodrogi L, Kazik M H. dehydroepiandrosterone concentration in adipose tissue of normal and overweight subjects.  Horm Metab Res. 1976;  8 372-374
  • 15 Bleau G, Roberts K D, Chapdelaine A. The in vitro and in vivo uptake and metabolism of steroids in human adipose tissue.  J Clin Endocrinol Metab. 1974;  39 236-246
  • 16 Longcope C, Pratt J H, Schneider S H, Fineberg S E. The in vivo metabolism of androgens by muscle and adipose tissue of normal men.  Steroids. 1976;  28 521-533
  • 17 Perel E, Killinger D W. The interconversion and aromatization of androgens by human adipose tissue.  J Steroid Biochem. 1979;  10 623-627
  • 18 Deslypere J P, Verdonck L, Vermeulen A. Fat tissue: a steroid reservoir and site of steroid metabolism.  J Clin Endocrinol Metab. 1985;  61 564-570
  • 19 Fehér T, Bodrogi L. A comparative study of steroid concentrations in human adipose tissue and the peripheral circulation.  Clin Chim Acta. 1982;  126 135-141
  • 20 Szymczak J, Milewicz A, Thijssen J HH, Blankenstein M A, Daroszewski J. Concentrations of sex steroids in adipose tissue after menopause.  Steroids. 1998;  63 319-321
  • 21 Borg W, Shackelton C HL, Pahuja S L, Hochberg R B. Long-lived testosterone esters in the rat.  Proc Natl Acad Sci U S A. 1995;  92 1545-1549
  • 22 Boulton K L, Hudson D U, Coppack S W, Frayn K N. Steroid hormone interconversions in human adipose tissue in vivo.  Metabolism. 1992;  41 556-559
  • 23 Roy R, Bélanger A. Formation of lipoidal steroids in follicular fluid.  J Steroid Biochem. 1989;  33 257-262
  • 24 Roy R, Bélanger A. Lipoproteins: carriers of dehydroepiandrosterone fatty acid esters in human serum.  J Steroid Biochem. 1989;  34 559-561
  • 25 Provencher P H, Roy R, Bélanger A. Pregnenolone fatty acid esters incorporated into lipoproteins: substrates in adrenal steroidogenesis.  Endocrinology. 1992;  130 2717-2724
  • 26 McTernan P G, Anwar A, Eggo M C, Barnett A H, Stewart P M, Kumar S. Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue.  Int J Obes. 2000;  24 875-881
  • 27 Price T, Aitken J, Head J, Mahendroo M, Means G, Simpson E. Determination of aromatase P450 messenger ribonucleic acid in human breast tissue by competitive polymerase chain reaction.  J Clin Endocrinol Metab. 1992;  74 1247-1252
  • 28 Bulun S E, Simpson E R. Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increases with advancing age.  J Clin Endocrinol Metab. 1994;  78 428-432
  • 29 Schmidt M, Löffler G. Induction of aromatase in stromal vascular cells from human breast adipose tissue depends on cortisol and growth factors.  FEBS Lett. 1994;  341 177-181
  • 30 Schmidt M, Loffler G. Induction of aromatase activity in human adipose tissue stromal cells by extracellular nucleotides-evidence for P2-purinoceptors in adipose tissue.  Eur J Biochem. 1998;  252 147-154
  • 31 Simpson E R, Merrill J C, Hollub A J, Graham-Lorence S, Mendelson C R. Regulation of estrogen biosynthesis by human adipose cells.  Endocr Rev. 1989;  10 136-148
  • 32 Zhao Y, Agarwal V R, Mendelson C R, Simpson E R. Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture.  J Steroid Biochem Molec Biol. 1997;  61 203-210
  • 33 Killinger D W, Perel E, Daniielscu D, Kharlip L, Lindsay W RN. Influence of adipose tissue distribution on the biological activity of androgens.  Ann NY Acad Sci. 1990;  595 199-211
  • 34 Perel E, Daniilescu D, Kindler S, Kharlip L, Killinger D W. The formation of 5alpha-reduced androgens in stromal cells from human breast adipose tissue.  J Clin Endocrinol Metab. 1986;  62 314-318
  • 35 Corbould A M, Bawden M J, Lavranos T C, Rodgers R J, Judd S J. The effect of obesity on the ratio of type 3 17beta-hydroxysteroid dehydrogenase mRNA to cytochrome P450 aromatase mRNA in subcutaneous abdominal and intra-abdominal adipose tissue of women.  Int J Obes. 2002;  26 165-175
  • 36 Folkerd E J, James V H. Studies on the activity of 17 beta-hydroxysteroid dehydrogenase in human adipose tissue.  J Steroid Biochem. 1982;  16 539-543
  • 37 Luu-The V, Labrie C, Simard J, Lachance Y, Zhao H F, Couet J, Leblanc G, Labrie F. Structure of two in tandem human 17 beta-hydroxysteroid dehydrogenase genes.  Mol Endocrinol. 1990;  4 268-275
  • 38 Labrie F, Simard J, Luu-The V, Trudel C, Martel C, Labrie C, Zhao H F, Rhéaume E, Couët J, Breton N. Expression of 3β-hydroxysteroid dehydrogenase/delta5-delta4 isomerase (3β-HSD) and 17β-hydroxysteroid dehydrogenase (17β-HSD) in adipose tissue.  Int J Obes. 1991;  15 91-99
  • 39 Seckl J R, Walker B R. 11β-hydroxysteroid dehydrogenase type 1 - a tissue specific amplifier of glucocorticoid action.  Endocrinology. 2001;  142 1371-1376
  • 40 Bujalska I J, Kumar S, Stewart P M. Does central obesity reflect “Cushing's syndrome of the omentum”?.  Lancet. 1997;  349 1210-1213
  • 41 Masuzaki H, Paterson J, Shinyama H, Morton N M, Mullins J J, Seckl J R, Flier J S. A transgenic model of visceral obesity and the metabolic syndrome.  Science. 2001;  294 2166-2170
  • 42 Yang K, Khalil M W, Strutt B J, Killinger D W. 11β-hydroxysteroid dehydrogenase 1 activity and gene expression in human adipose stromal cells: effects on aromatase activity.  J Steroid Biochem Molec Biol. 1997;  60 247-253
  • 43 Weidenfeld J, Siegel R A, Levy J, Chowers I. In vitro metabolism of cortisol by human abdominal adipose tissue.  J Steroid Biochem. 1982;  17 357-360
  • 44 Katz J R, Mohamed-Ali V, Wood P J, Yudkin J S, Coppack S W. An in vivo study of the cortisol-cortisone shuttle in subcutaneous abdominal adipose tissue.  Clin Endocrinol. 1999;  50 63-68
  • 45 Bujalska I J, Walker E A, Hewison M, Stewart P M. A switch in dehydrogenase to reductase activity of 11β-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells.  J Clin Endocrinol Metab. 2002;  87 1205-1210
  • 46 Longcope C, Fineberg S E. Production and metabolism of diydrotestosterone in pheripheral tissues.  J Steroid Biochem. 1985;  23 415-419
  • 47 Puche C, José M, Meseguer A. Expression and enzymatic activity of the P450c17 gene in human adipose tissue.  Eur J Endocrinol. 2002;  146 223-229
  • 48 Tchernof A, Labrie F, Bélanger A, Prud'homme D, Bouchard C, Tremblay A, Nadeau A, Després J P. Androstane-3α,17β-diol glucuronide as a steroid correlate of visceral obesity in men.  J Clin Endocrinol Metab. 1997;  82 1528-1534
  • 49 Pritchard J, Després J P, Gagnon J, Tchernof A, Nadeau A, Tremblay A, Bouchard C. Plasma adrenal, gonadal and conjugated steroids before and after long term overfeeding in identical twins.  J Clin Endocrinol Metab. 1998;  83 3277-3284
  • 50 Beaulieu M, Levesque E, Hum D W, Belanger A. Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11.  Biochem Biophys Res Commun. 1998;  248 44-50
  • 51 Bolander F F. Molecular endocrinology. New York; Academic Press 1989
  • 52 Elbers J MH, Asscheman H, Seidell J C, Megens J A, Gooren L JG. Long-term testosterone administration increases visceral fat in female to male transsexuals.  J Clin Endocrinol Metab. 1997;  82 2044-2047
  • 53 Barrett-Connor E L. Testosterone and risk factors for cardiovascular disease in men.  Diabete Metab. 1995;  21 156-161
  • 54 Strain G W, Zumoff B, Kream J, Strain J J, Deucher R, Rosenfeld R S, Levin J, Fukushima D K. Mild hypogonadotropic hypogonadism in obese men.  Metabolism. 1982;  31 871-875
  • 55 Glass A R, Swerdloff R S, Bray G A, Dahms W T, Atkinson R L. Low serum testosterone and sex-hormone-binding-globulin in massively obese men.  J Clin Endocrinol Metab. 1977;  45 1211-1219
  • 56 Tchernof A, Després J P, Bélanger A, Dupont A, Prud'homme D, Moorjani S, Lupien P J, Labrie F. Reduced testosterone and adrenal C19 steroid levels in obese men.  Metabolism. 1995;  44 513-519
  • 57 Seidell J C, Björntorp P, Sjöström L, Kvist H, Sannrstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels.  Metabolism. 1990;  39 897-901
  • 58 Pasquali R, Casimirri F, Cantobelli S, Melchionda N, Morselli Labate A M, Fabbri R, Capelli M, Bortoluzzi L. Effect of obesity and body fat distribution on sex hormones and insulin in men.  Metabolism. 1991;  40 101-104
  • 59 Björntorp P. Endocrine abnormalities in obesity.  Diabetes Rev. 1997;  5 52-68
  • 60 Amatruda J M, Harman S M, Pourmotabbed G, Lockwood D H. Depressed plasma testosterone and fractional binding of testosterone in obese males.  J Clin Endocrinol Metab. 1978;  47 268-271
  • 61 Björntorp P. Endocrine abnormalities of obesity.  Metabolism. 1995;  44 (Suppl. 3) 1-23
  • 62 Xu X, de Pergola G, Björntorp P. The effects of androgens on the regulation of lipolysis in adipose precursor cells.  Endocrinology. 1990;  126 1229-1234
  • 63 Mårin P, Odén B, Björntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens.  J Clin Endocrinol Metab. 1995;  80 239-243
  • 64 Mårin P, Rebuffé-Scrive M, Björntorp P. Uptake of triglyceride fatty acids in adipose tissue in vivo in man.  Eur J Clin Invest. 1990;  20 158-165
  • 65 Dieudonne M N, Pecquery R, Boumediene A, Leneveu M C, Giudicelli Y. Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids.  Am J Physiol. 1998;  274 C1645-C1652
  • 66 de Pergola G, Xu X, Yang S, Giorgino R, Björntorp P. Up-regulation of androgen receptor binding in male rat fat pad adipose precursor cells exposed to testosterone: study in a whole cell assay system.  J Steroid Biochem Molec Biol. 1990;  4 553-558
  • 67 Pedersen S B, Fuglsig S, Sjögren P, Richelsen B. Identification of steroid receptors in human adipose tissue.  Eur J Clin Invest. 1996;  26 1051-1056
  • 68 Joyner J, Hutley L, Cameron D. Intrinsic regional differences in androgen receptors and dihydrotestosterone metabolism in human preadipocytes.  Horm Metab Res. 2002;  34 223-228
  • 69 Tchernof A, Poehlman E T. Effects of the menopause transition on body fatness and body fat distribution.  Obesity Res. 1998;  6 246-254
  • 70 Tchernof A, Calles-Escandon J, Sites C K, Poehlman E T. Menopause, central body fatness, and insulin resistance: effects of hormone replacement therapy.  Coron Artery Dis. 1998;  9 503-511
  • 71 Tchernof A, Poehlman E T, Després J P. Body fat distribution, the menopause transition, and hormone replacement therapy.  Diabete Metab. 2000;  26 12-20
  • 72 Ciocca D R, Vargas R oig. Estrogen receptors in human nontarget tissues: Biological and clinical implications.  Endocr Rev. 1995;  16 35-62
  • 73 Crandall D L, Busler D E, Novak T J, Weber R V, Kral J G. Identification of estrogen receptor β RNA in human breast and abdominal subcutaneous adipose tissue.  Biochem Biophys Res Commun. 1998;  248 523-526
  • 74 Pedersen S B, Borglum J D, Eriksen E F, Richelsen B. Nuclear estradiol binding in rat adipocytes. Regional variations and regulatory influences of hormones.  Biochim Biophys Acta. 1991;  1093 80-86
  • 75 Pedersen S B, Borglum J D, Moller-Pedersen T, Richelsen B. Effects of in vivo estrogen treatment on adipose tissue metabolism and nuclear estrogen receptor binding in isolated rat adipocytes.  Mol Cell Endocrinol. 1992;  85 13-19
  • 76 Pedersen S B, Hansen P S, Lund S, Andersen P H, Odgaard A, Richelsen B. Identification of oestrogen receptors and oestrogen receptor mRNA in human adipose tissue.  Eur J Clin Invest. 1996;  26 262-269
  • 77 Mizutani T, Nishikawa Y, Adachi H, Enomoto T, Ikegami H, Kurachi H, Nomura T, Miyake A. Identification of estrogen receptor in human adipose tissue and adipocytes.  J Clin Endocrinol Metab. 1994;  78 950-954
  • 78 Price T M, O'Brien S N. Determination of estrogen receptor messenger ribonucleic acid (mRNA) and cytochrome P450 aromatase mRNA levels in adipocytes and adipose stromal cells by competitive polymerase chain reaction amplification.  J Clin Endocrinol Metab. 1993;  77 1041-1045
  • 79 Rask E, Walker B R, Söderberg S, Livingstone D EW, Eliasson M, Johnson O, Andrew R, Olsson T. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose tissue 11β-hydroxysteroid dehydrogenase type 1 activity.  J Clin Endocrinol Metab. 2002;  87 3330-3336
  • 80 Harris M I, Flegal K M, Cowie C C, Eberhardt M S, Goldstein D E, Little R R, Wiedmeyer H M, Byrd-Holt D D. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults.  Diabetes Care. 1998;  21 518-524
  • 81 Mokdad A H, Ford E S, Bowman B A, Nelson D E, Engelgau M M, Vinicor F, Marks J S. The continuing increase of diabetes in the U.S.  Diabetes Care. 2001;  24 412
  • 82 Mokdad A H, Serdula M K, Dietz W H, Bowman B A, Marks J S, Koplan J P. The spread of the obesity epidemic in the United States, 1991 - 1998.  JAMA. 1999;  282 1519-1522
  • 83 Seidell J C, Flegal K M. Assessing obesity: classification and epidemiology.  Br Med Bull. 1997;  53 238-252
  • 84 Mokdad A H, Ford E S, Bowman B A, Nelson D E, Engelgau M M, Vinicor F, Marks J S. Diabetes trends in the U.S.: 1990 - 1998.  Diabetes Care. 2000;  23 1278-1283
  • 85 Must A, Spadano J, Coakley E H, Field A E, Colditz G, Dietz W H. The disease burden associated with overweight and obesity.  JAMA. 1999;  282 1523-1529
  • 86 Killinger D W, Strutt B J, Roncari D A, Khalil M W. Estrone formation from dehydroepiandrosterone in cultured human breast adipose stromal cells.  J Steroid Biochem Molec Biol. 1995;  52 195-201
  • 87 Rask E, Olsson T, Soderberg S, Andrew R, Livingstone D E, Johnson O, Walker B R. Tissue-specific dysregulation of cortisol metabolism in human obesity.  J Clin Endocrinol Metab. 2001;  86 418-421
  • 88 Tomlinson J W, Moore J, Cooper M S, Bujalska I, Shahmanesh M, Burt C, Strain A, Hewison M, Stewart P M. Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines.  Endocrinology. 2001;  142 1982-1989
  • 89 Ricketts M L, Verhaeg J M, Bujalska I, Howie A J, Rainey W E, Stewart P M. Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues.  J Clin Endocrinol Metab. 1998;  83 1325-1335
  • 90 Moore J S, Monson J P, Kaltsas G, Putignano P, Wood P J, Sheppard M C, Besser G M, Taylor N F, Stewart P M. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies.  J Clin Endocrinol Metab. 1999;  84 4172-4177
  • 91 Bujalska I J, Kumar S, Hewison M, Stewart P M. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase.  Endocrinology. 1999;  140 3188-3196
  • 92 Tait G H, Newton C J, Reed M J, James V H. Multiple forms of 17 beta-hydroxysteroid oxidoreductase in human breast tissue.  J Mol Endocrinol. 1989;  2 71-80
  • 93 Mann V Z, Newton C J, Tait G H. 17 Beta-hydroxysteroid dehydrogenases in human breast tissues: purification and characterization of soluble enzymes and the distribution of particulate and soluble forms in adipose, non-adipose and tumour tissues.  J Mol Endocrinol. 1991;  7 45-55
  • 94 Labrie F, Luu-The V, Lin S X, Labrie C, Simard J, Breton R, Belanger A. The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology.  Steroids. 1997;  62 148-158
  • 95 Khalil M W, Strutt B, Vachon D, Killinger D W. Metabolism of dehydroepiandrosterone by cultured human adipose stromal cells: identification of 7 alpha- hydroxydehydroepiandrosterone as a major metabolite using high performance liquid chromatography and mass spectrometry.  J Steroid Biochem Molec Biol. 1993;  46 585-595
  • 96 Khalil M W, Strutt B, Vachon D, Killinger D W. Effect of dexamethasone and cytochrome P450 inhibitors on the formation of 7alpha-hydroxydehydroepiandrosterone by human adipose stromal cells.  J Steroid Biochem Molec Biol. 1994;  48 545-552
  • 97 Lévesque E, Beaulieu M, Green M D, Tephly T R, Bélanger A, Hum D W. Isolation and characterization of UGT2B15 (Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene.  Phamacogenetics. 1997;  7 317-325
  • 98 Tchernof A, Lévesque E, Beaulieu M, Couture P, Després J P, Hum D W, Bélanger A. Expression of the androgen metabolizing enzyme UGT2B15 in adipose tissue and relative expression measurement using a competitive RT-PCR method.  Clin Endocrinol. 1999;  50 637-642

A. Tchernof, Ph.D. 

Molecular Endocrinology and Oncology Research Center · Laval University Hospital Research Center

2705 Laurier blvd. (T3-67) Quebec, Qc · Canada G1V 4G2 ·

Phone: + 1 (418) 654-2296

Fax: + 1 (418) 654-2761

Email: andre.tchernof@crchul.ulaval.ca

    >